Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 26, 2017 - Issue 10
Submit an article Journal homepage
754
Views
6
CrossRef citations to date
0
Altmetric
Review

Combination therapy with the type II anti-CD20 antibody obinutuzumab

Christian KleinRoche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Zurich, SwitzerlandCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-7594-7280View further author information
ORCID Icon,
Marina BacacRoche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Zurich, SwitzerlandView further author information
,
Pablo UmanaRoche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Zurich, SwitzerlandView further author information
&
Günter Fingerle-RowsonPharma Development Clinical Oncology, F. Hoffmann-La Roche Ltd, Basel, SwitzerlandView further author information
Pages 1145-1162 | Received 15 May 2017, Accepted 25 Aug 2017, Published online: 06 Sep 2017

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Omid Rezahosseini, Sara Hanaei, Mehdi Hamadani, Mahsa Keshavarz-Fathi & Nima Rezaei. (2018) The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma. International Reviews of Immunology 37:3, pages 165-173.
Read now

Articles from other publishers (5)

Hossein Panjideh, Nicole Niesler, Alexander Weng & Hendrik Fuchs. (2022) Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 14:7, pages 478.
Crossref
Romeo G. Mihăilă. (2020) Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology. Recent Patents on Anti-Cancer Drug Discovery 15:4, pages 272-292.
Crossref
Loic Ysebaert & Franck Morschhauser. (2020) Immunomodulatory Agents in Follicular Lymphoma. Hematology/Oncology Clinics of North America 34:4, pages 715-726.
Crossref
Christian Klein, Wolfgang Schaefer, Joerg T. Regula, Charles Dumontet, Ulrich Brinkmann, Marina Bacac & Pablo Umaña. (2019) Engineering therapeutic bispecific antibodies using CrossMab technology. Methods 154, pages 21-31.
Crossref
Morie A. Gertz. (2018) Selecting Initial Therapy for Newly Diagnosed Waldenström Macroglobulinemia. Journal of Clinical Oncology 36:27, pages 2749-2751.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.